NFL Legend Carl Banks Partners With SPO
Company Prepares for Commercial Launch of its New Consumer Product Line
NEW YORK, June 2, 2011 /PRNewswire-FirstCall/ -- SPO (SPOM.OB), a leading developer of biosensor and microprocessor technologies for consumer wellness applications, today announced it has secured the services of Carl Banks to assist in the sales and marketing program of its SPO Wellness(TM) product line. Mr. Banks will support SPO in implementing the mass-market distribution strategy of the Company.
The initial product being launched by SPO is the Wellness 10k(TM) wristband featuring a display function that continuously measures the number of daily activities against preset recommended goals. Additional products under development include a heart-rate monitor sports watch to measure continuous heart-rate without the need to wear a conventional chest strap.
Michael Braunold, President and Chief Executive Officer of SPO, commented, "We are delighted to have Carl Banks join our team - Carl brings with him many years of experience both as a successful NFL player and in the retail apparel business. He is held in high regard as a legend player and more recently for his commercial activities with licensing of sports apparel. We believe his involvement with the SPO Wellness(TM) product line will greatly enhance our ability to successfully launch our product offers in the consumer mass-market."
Carl Banks commented, "I'm excited to assist in the sales and marketing efforts of the SPO Wellness(TM) product line - these products will support individuals who desire to live healthier lives and perform their daily activities in a smart and responsible way leading to a greater awareness of how to improve overall wellness. My many years as an NFL player and experience in the commercial retail environment is a winning combination to best assist SPO achieve its goals. Through my extensive retail distribution network, I plan to do my personal best to make it happen for SPO and its unique product offerings."
Carl Banks' interest over many years in fashion and his playing experience at the New York Giants proved to be a winning combination. Banks secured an NFL license to distribute his branded clothing product line to major US retailers. In his current position as President of Sports Licensing at the G-III Apparel Group, Ltd, Banks secured an exclusive license from the NFL and NBA. The G-III Apparel/Carl Banks product line also holds licenses for NHL, NASCAR, Collegiate, Starter Corp., and Louisville Slugger.
After a successful test-marketing program for the Wellness 10k(TM) wristband, SPO has commenced preparations for full commercial roll-out. Braunold continued, "We believe the sales and marketing experience of Carl Banks will help us bring a cost-effective solution to the vast consumer wellness market, which in turn contributes to potentially increasing value for the SPO shareholders."
About Carl Banks
Carl E. Banks was a football linebacker in the NFL playing for the New York Giants, Washington Redskins and the Cleveland Browns from 1984 to 1995. He made the Pro Bowl in 1987, had 39.5 career quarterback sacks, and was a member of the NFL's 1980's All-Decade Team. He played college football at Michigan State University and was the third overall pick in the 1984 NFL Draft. Banks was a member of the Giants teams that won Super Bowls XXI and XXV as well as playing a key roll recording 14 total tackles, including ten solo tackles at the Super Bowls XXI. After retiring from the NFL, Banks was a Director of Player Development for the New York Jets. Currently, Banks is President of Sports Licensing at the G-III Apparel Group, Ltd and an analyst for the radio broadcasts of the New York Giants.
About SPO
SPO (SPOM.OB) is a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-enhancing information within four key markets: medical care; sports and wellness; homecare monitoring and security. Its patented technology uses information gathered from the reflectance of light on the human body, in a noninvasive manner, to monitor key vital signs. The company manufactures its products in addition to licensing its technologies to appropriate client corporations for commercialization and distribution. For more information, visit http://www.spoglobal.com.
Forward Looking Statements
This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, market acceptance of our products and new product applications, timing of new product launches, success of the Company's rebranding program, product performance, size of prospective markets, revenues assessments, success of our restructured operations and plans, our ability to generate fees or raise capital to support our business operations and plan, the sufficiency and availability of working capital, changes in economic conditions generally and in more specifically, the introduction of competing products, changes in our operating strategy or development plans patent protection for our products and technologies, changes in economic conditions generally and in more specifically, in the markets we operate, changes in technology, legislative or regulatory changes that affect us and the risks and uncertainties discussed under the heading "Risk Factors" in Item 1 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2010. We undertake no obligation to revise or update any forward-looking statement for any reason.
Websites: http://www.spoglobal.com; http://www.spowellness.com; Twitter: http://www.twitter.com/spowellness Facebook: http://www.facebook.com/spowellness Contact regarding this release: [email protected], +1-866-991-7766
SOURCE SPO Medical Inc
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article